The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Adult vaccines continue to be one of the growing segment for pharmaceutical companies. The driving factors for adult vaccines growth are an increasing acceptance of adult vaccines and the public health focus on flu prevention, as well as introductions of new vaccines. The vaccines industry also faces hindrances such as vaccine safety, shortages and delays, vaccine development time line as well as entry barriers for new manufacturers.
Browse the complete report @ http://www.orbisresearch.com/reports/index/global-adult-vaccines-market-company-analysis-and-forecast-to-2021 .
Adult Vaccines Market – Disease Wise Analysis:
The influenza vaccines capture maximum share of the total adult vaccines market. It is the most popular and accepted vaccination amongst adults. The hepatitis vaccines account for second highest share of the total adult vaccines market in 2015. The HPV/cervical cancer vaccines and pneumococcal vaccines captures the third and fourth highest share of the adult vaccines market respectively in 2015. While vaccines for zoster shingles and DTP are also gaining ground in adult vaccines market landscape.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/175229 .
Adult Vaccines Market – Company Analysis:
Note: Novartis divested its non-influenza vaccine business to GlaxoSmithKline (GSK) and CSL acquired Novartis influenza vaccines business.
In 2010, GSK was the leader in the adult vaccines market but it lost the leadership position to Merck. Sanofi Pasteur stands at the second position in the adult vaccines market landscape. GSK slipped to third position in the global adult vaccines market in 2014. While Pfizer stands at the fourth spot in the adult vaccines market landscape.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/175229 .
List of Tables:
Table 3-1: Global – Disease Wise Adults Vaccinated Share (Percent), 2010 – 2015
Table 3-2: Global – Forecast for Disease Wise Adults Vaccinated Share (Percent), 2016 – 2021
Table 3-3: Global Adult Vaccines – Disease Wise Market Share (Percent), 2010 – 2015
Table 3-4: Global Adult Vaccines – Forecast for Disease Wise Market Share (Percent), 2016 – 2021
Table 3-5: Global Adult Vaccines – Company Wise Market Share (Percent), 2010 – 2015
Table 3-6: Global Adult Vaccines – Forecast for Company Wise Market Share (Percent), 2016 – 2021
Table 3-7: Influenza Adult Vaccines – Company Market Share (Percent), 2010 – 2015
Table 3-8: Influenza Adult Vaccines – Forecast for Company Market Share (Percent), 2016 – 2021
Table 8-1: Worldwide – Major Vaccine Related Acquisitions, (2005 – 2015)
Table 9-1: Global – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020
Table 9-2: Global Goal-Level Indicators, 2015 & 2020
Table 9-3: Improvement Strategies or Requirements – the Joint Commission and the Project’s Collaborating Organizations
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: firstname.lastname@example.org